N Emmanuel Diaz-Martinez
Overview
Explore the profile of N Emmanuel Diaz-Martinez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valadez-Barba V, Cota-Coronado A, Hernandez-Perez O, Lugo-Fabres P, Padilla-Camberos E, Diaz N, et al.
Regen Ther
. 2021 Jan;
15:332-339.
PMID: 33426236
Neurodegenerative disorders such as Parkinson's and Alzheimer's disease, are fundamental health concerns all around the world. The development of novel treatments and new techniques to address these disorders, are being...
2.
Juarez-Navarro K, Padilla-Camberos E, Diaz N, Miranda-Altamirano A, Diaz-Martinez N
Stem Cells Int
. 2021 Jan;
2020:8892189.
PMID: 33414832
Mesenchymal stem cells (MSCs), defined as plastic adherent cells with multipotent differentiation capacity in vitro, are an emerging and valuable tool to treat a plethora of diseases due to their...
3.
Cota-Coronado A, Durnall J, Diaz N, Thompson L, Diaz-Martinez N
Molecules
. 2020 Mar;
25(5).
PMID: 32143423
Human induced pluripotent stem cells (hiPSCs) have transformed conventional drug discovery pathways in recent years. In particular, recent advances in hiPSC biology, including organoid technologies, have highlighted a new potential...
4.
Cota-Coronado A, Thompson L, Diaz-Martinez N
Neural Regen Res
. 2019 Sep;
15(2):255-256.
PMID: 31552892
No abstract available.
5.
Cota-Coronado A, Diaz-Martinez N, Padilla-Camberos E, Diaz-Martinez N
Front Mol Neurosci
. 2019 Jun;
12:110.
PMID: 31191241
The translational gap to treatments based on gene therapy has been reduced in recent years because of improvements in gene editing tools, such as the CRISPR/Cas9 system and its variations....
6.
Cota-Coronado A, Ramirez-Rodriguez P, Padilla-Camberos E, Diaz E, Flores-Fernandez J, Avila-Gonzalez D, et al.
Drug Discov Today
. 2018 Oct;
24(1):334-341.
PMID: 30292915
Human induced pluripotent stem cells (hiPSCs) enable in vitro high-throughput pharmacological screening assays of diseased tissue. Together with recent genome-wide association studies (GWAS), hiPSCs enable the identification of key mutations...
7.
Diaz-Martinez N, Tamariz E, Diaz N, Garcia-Pena C, Varela-Echavarria A, Velasco I
Mol Ther
. 2013 Jun;
21(8):1579-91.
PMID: 23732989
Cell therapy in animal models of Parkinson's disease (PD) is effective after intrastriatal grafting of dopamine (DA) neurons, whereas intranigral transplantation of dopaminergic cells does not cause consistent behavioral recovery....
8.
Tamariz E, Diaz-Martinez N, Diaz N, Garcia-Pena C, Velasco I, Varela-Echavarria A
J Neurosci Res
. 2009 Oct;
88(5):971-80.
PMID: 19859963
Class 3 Semaphorins are a subfamily of chemotropic molecules implicated in the projection of dopaminergic neurons from the ventral mesencephalon and in the formation of the nigrostriatal pathway (NSP) during...